Further evidence that Cerebrolysin® protects cortical neurons from neurodegeneration in vitro

  • B. Hutter-Paier
  • E. Grygar
  • M. Frühwirth
  • I. Temmel
  • M. Windisch
Part of the Journal of Neural Transmission. Supplementa book series (NEURAL SUPPL, volume 53)


The effects of Cerebrolysin® on isolated chicken cortical neurons in an iron induced oxidative stress model and in a combined iron-glutamate model have been examined. In a first part of experiments it has been shown that under low serum conditions exposure of neurons to different concentrations of ammonium-iron(III)citrate (1, 5μM AC-Fe3+) for 8 days caused a significant reduction in neuronal survival. Cerebrolysin® not only prevented iron induced neurodegeneration, demonstrating that ionic iron was responsible for the cell damage, moreover, it increased the neuronal viability up to tenfold with respect to the controls. In the second part of the study neurons pre-incubated for 8 days with AC-Fe3+ were additionally lesioned with 1 mM L-glutamate and allowed to recover for another 48h. Under these conditions cerebrolysin again clearly counteracted the in vitro destructive effects of glutamate. Besides consequences on the viability and survival of neurons Cerebrolysin® increased abundance of the microtubule-associated protein MAP2, which is known to play a an important role in maintaining normal neuronal function.


Cortical Neuron Neuronal Viability Nutrition Medium Nootropic Drug Cere Group 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Berlove D, Caday C, Moskowitz M, Finklestein S (1991) Basic fibroblast growth factor (bFGF) protects against ischemic neuronal death in vivo. Soc Neurosci Abstr 17: 1267Google Scholar
  2. Cheng B, Mattson M (1991) NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 7: 1031–1041PubMedCrossRefGoogle Scholar
  3. Cheng B, Mattson MP (1994) NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res 640: 56–67PubMedCrossRefGoogle Scholar
  4. Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease. J Neurochem 52: 381–389PubMedCrossRefGoogle Scholar
  5. Dux E, Schubert P, Kreuzberg GW (1992) Ultrastructural localization of calcium in ischemic hippocampal slices: the influence of adenosine and theophylline. J Cereb Blood Flow Metab 12: 520–524PubMedCrossRefGoogle Scholar
  6. Good PF, Perl DP, Bierer LM, Schmeidler J (1992) Selective accumulation of aluminium and iron in the neurofibrillary tangels of Alzheimer’s disease: a laser microprobe (LAMMA) study. Ann Neurol 31: 286–292PubMedCrossRefGoogle Scholar
  7. Goodman SR, Zagon IS (1986) The neural cell spectrin skeleton: a review. Am J Physiol 250: 347–360Google Scholar
  8. Gschanes A, Valouskova V, Windisch M (1997) Ameliorative influence of a nootropic drug on motor activity of rats after bilateral carotid artery occlusion. J Neural Transm 104: 1319–1327PubMedCrossRefGoogle Scholar
  9. Guthrie PB, Segal M, Kater SB (1991) Independent regulation of calcium revealed by imaging dendritic spines. Nature 354: 76–80PubMedCrossRefGoogle Scholar
  10. Hall DE (1992) Novel inhibitors of iron-dependent lipid peroxidation for neurode-generative disorders. Ann Neurol 32: 137–142CrossRefGoogle Scholar
  11. Hutter-Paier B, Grygar E, Windisch M (1996) Death of cultured telencephalon neurons induced by glutamate is reduced by the peptide derivative cerebrolysin. J Neural Transm 47: 267–273CrossRefGoogle Scholar
  12. Iacopino AM, Christakos S, Altar CA (1990) NGF augments the calcium binding protein, calbindin-28k, in rat olfactory bulb in vivo. Soc Neurosci Abstr 16: 482Google Scholar
  13. Jellinger K, Kienzl E, Rumpelmair G, Riederer P, Stachelberger H, Ben Shachar D, Youdim BH (1992) Iron-melanin complex in substantia nigra of Parkinsonian brains: an X-ray microanalysis. J Neurochemistry 59: 1168–1171CrossRefGoogle Scholar
  14. Kusumoto M, Dux E, Hossmann K-A (1997) Effect of trophic factors on delayed neuronal death induced by in vitro ischemia in cultivated hippocampal and cortical neurons. Metab Brain Dis 12: 113–120PubMedGoogle Scholar
  15. Matesic, Diane F, Rick CS, Lin (1994) Microtubule-associated protein 2 as an early indicator of ischemia-induced neurodegeneration in the gerbil forebrain. J Neurochem 63: 1012–1020PubMedCrossRefGoogle Scholar
  16. Mattson MP, Zhang Y, Bose S (1993a) Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp Neurol 121: 1–13PubMedCrossRefGoogle Scholar
  17. Mattson MP, Cheng B (1993b) Growth factors protect neurons against excitotoxic/ ischemic damage by stabilizing calcium homeostasis. Stroke 24: 136–140Google Scholar
  18. Mattson PM, Cheng BIN and Smith-Swintoski VL (1993c) Mechanisms of neurotrophic factor protecting against calcium-and free radical-mediated excitotoxic injury: implications for treating neurodegenerative disorders. Exp Neurol 124: 89–95PubMedCrossRefGoogle Scholar
  19. Meldrum BS (1990) Protection against ischemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc Brain Metab Rev 2: 27–57PubMedGoogle Scholar
  20. Monyer H, Hartley DM, Choi DW (1990) 21-aminosteroids attenuate excitoxic neuronal injury in cortical cell cultures. Neuron 5: 121–126PubMedCrossRefGoogle Scholar
  21. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55–63PubMedCrossRefGoogle Scholar
  22. Muller W, Connor JA (1991) Dendritic spines an individual neuronal compartments for synaptic Ca++ responses. Nature 354: 73–76PubMedCrossRefGoogle Scholar
  23. Nistico G, Ciriolo MR, Fiskin D, Iannone M, DeMartino A, Rotilio G (1992) NGF restores decrease in catalase activity and increases Superoxide dismutase and glutathione peroxidase activity in the brain of aged rats. Free Rad Biol Med 12: 177–181PubMedCrossRefGoogle Scholar
  24. Olney W (1993) Role of excitotoxins in developmental neuropathology. APMIS 40/101: 103–112Google Scholar
  25. Otto D, Unsicker K (1990) Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J Neurosci 10: 1912–1920PubMedGoogle Scholar
  26. Pettmann B, Louis JC, Sensenbrenner M (1979) Morphological and biochemical maturation of neurones cultured in the absence of glial cells. Nature 281: 378–380PubMedCrossRefGoogle Scholar
  27. Rüther E, Ritter R, Apecechea M, Freytag S, Windisch M (1994) Efficacy of the peptidergic drug cerebrolysin in patients with senile dementia of the Alzheimer’s type (SDAT). Pharmacopsy 27: 32–37CrossRefGoogle Scholar
  28. Sandoval IV, Weber K (1978) Calcium-induced inactivation of microtubule formation in brain extracts: presence of a calciumdependent protease acting on polymerization-stimulating microtubule-associated proteins. Eur J Biochem 92: 463–470PubMedCrossRefGoogle Scholar
  29. Smith MA, Perry G (1995) Free radical damage, iron, and Alzheimer’s disease. J Neurol Sci 134: 92–94PubMedCrossRefGoogle Scholar
  30. Schwab M, Bauer R, Zwiener U (1997) Physiological effects and brain protection by hypothermia and cerebrolysin after moderate forebrain ischemia in rats. Exp Toxicol Pathol 49: 105–116PubMedCrossRefGoogle Scholar
  31. Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenyl-pyridinium ion toxicity: Involvement of glutathione system. J Neurochem 59: 99–106PubMedCrossRefGoogle Scholar
  32. Willmore LJ, Rubin JJ (1982) Formation of malonaldehyde and focal brain edema indced by subpial injection of FeCl2 into rat isocortex. Brain Res 246: 113–119PubMedCrossRefGoogle Scholar
  33. Zhang Y, Tatsuno T, Carney JM, Mattson MP (1993) Basic FGF, NGF, and IGFs protect hippocampal and cortical neurons against iron-induced degeneration. J Cereb Blood Flow Metabol 13: 378–388CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 1998

Authors and Affiliations

  • B. Hutter-Paier
    • 1
  • E. Grygar
    • 1
  • M. Frühwirth
    • 1
  • I. Temmel
    • 1
  • M. Windisch
    • 1
  1. 1.Research Initiative EBEWEInstitute of Experimental PharmacologyGrazAustria

Personalised recommendations